Skip to content

GRI Bio, Inc.

GRI· NasdaqCore metricsCIK 1824293

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -1.09%
Market cap
$3.98M
2.19M shares
Filings
409
$0.00
Q1 2022−100.0% FY21 yoy
-$1.51M
Q3 2026N/M FY25 yoy
-$1.51M
Q3 2026N/M FY25 yoy
-$10.19M
FY 2025derivedN/M FY25 yoy
-$0.69
Q3 2026N/M FY25 yoy
$9.47M
Q3 2026+63.7% FY25 yoy
$3.98M
—
—
0.5×
-256.09%
—

FY2025 figures · derived

Price

$1.8296.47%$49.72past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2021
$100.00K0FY 2020FY 2021
PeriodEndedValueKindSource trail
FY 20212021-12-31$0reported
FY 20202020-12-31$100,000reported

Pharmaceutical preparations

GRI Bio, Inc. is the 460th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR